America's cancer care crisis-is Europe any better?

The Lancet

Volumn 382, Issue 9905, 2013, Pages 1628-

  Lawler, Mark ^a   Duffy, Sean ^c   La Vecchia, Carlo ^d   Le Chevalier, Thierry ^e   Selby, Peter J ^f   Sullivan, Richard ^g   Johnston, Patrick G ^a,b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c NATIONAL HEALTH SERVICE   (United Kingdom)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f UNIVERSITY OF LEEDS   (United Kingdom)

^g KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE INHIBITOR;

AGING; ALLOGENEIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; DRUG COST; EASTERN EUROPE; EUROPE; HEALTH CARE POLICY; HUMAN; INTENTION TO TREAT ANALYSIS; LETTER; MALIGNANT NEOPLASTIC DISEASE; OUTCOME ASSESSMENT; PATIENT CARE; PHILOSOPHY; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL RATE; UNITED STATES; WHOLE BODY RADIATION; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL OUTCOME; DELAYED DIAGNOSIS; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; INTERNATIONAL COOPERATION; MALIGNANT NEOPLASM; TERMINAL CARE;

DELIVERY OF HEALTH CARE; HUMANS; NEOPLASMS;

EID: 85047699445     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)62362-4     Document Type: Letter

References (5)

1. Institute of Medicine. Delivering high-quality cancer care: charting a new course for a system in crisis. http://www.nap.edu/catalog.php?record-id= 18359 (Accessed Sept 11, 2013).
2. The Lancet. America's cancer care crisis. Lancet 2013; 382: 913.
3. Coleman MP, Forman D, Bryant H., et al Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011; 377: 127-38.
4. Bosetti C, Bertuccio P, Malvezzi M., et al Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol 2013; 24: 2657-71.
5. Experts in Chronic Myeloid Leukemia. The price of drugs for Chronic Myeloid Leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts. Blood 2013; 121: 4439-42.